technetium tc 99m sestamibi has been researched along with rubidium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Friedrich, M; Schoeder, H; Topp, H | 1 |
| Giorgi, MC; Izaki, M; Meneghetti, JC; Padilha, BG; Sabino, D; Soares, J | 1 |
| Ageeli, WA; Alanazi, SF; Alenezi, MM; Alyami, AS; Majrashi, NA; Refaee, TA; Salawi, MH; Sharif, H | 1 |
2 review(s) available for technetium tc 99m sestamibi and rubidium
| Article | Year |
|---|---|
Myocardial viability: what do we need?
Topics: Heart; Humans; Myocardial Ischemia; Myocardium; Rubidium; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed | 1993 |
A systemic review of rubidium-82 PET contrasted with 99mTc-MIBI SPECT for imaging coronary artery disease.
Topics: Coronary Artery Disease; Humans; Positron-Emission Tomography; Rubidium; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2023 |
1 other study(ies) available for technetium tc 99m sestamibi and rubidium
| Article | Year |
|---|---|
Case Report: Multivessel Coronary Disease Assessment with SPECT 99mTc-Sestamibi and Rubidium-82 PET/CT.
Topics: Coronary Angiography; Coronary Artery Disease; Female; Fractional Flow Reserve, Myocardial; Humans; Middle Aged; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Rubidium; Technetium Tc 99m Sestamibi | 2017 |